Interventional Radiology Gains C-Suite Influence
Leaders from Mount Sinai are projecting that interventional radiology (IR) is poised for significant strategic gains within health system leadership in 2026. The commentary describes the specialty's evolution from a technical service in the "basement to the C-suite" as it becomes a more comprehensive and strategically important service line.
- The global market for interventional radiology products is projected to grow from $10.2 billion in 2021 to $14.1 billion by 2026, driven by an aging population and the increasing prevalence of chronic diseases. Concurrently, the total interventional radiology market is expected to expand from $32.64 billion in 2026 to $55.93 billion by 2035. - A significant trend influencing IR's strategic importance is the shift of imaging services from hospitals to outpatient settings, with approximately 40% of all radiology volume now occurring in outpatient centers or clinics. This move is largely driven by payers aiming to reduce costs, as exemplified by policies from insurers like Cigna, Anthem, and UnitedHealthcare that restrict MRIs and CTs in more expensive hospital-based departments. - Health systems are responding to these site-of-care shifts by acquiring or developing their own freestanding imaging assets. Shifting just 10% of hospital-based care to outpatient settings could yield an estimated $125 billion in annual savings for the U.S. healthcare system. - Technology is a major driver of IR's expanding influence, with artificial intelligence enhancing pre-procedural planning, real-time decision-making during procedures, and post-procedural assessment. The integration of AI with robotics and advanced imaging techniques is making procedures more precise and less invasive. - Despite its growth, the field faces a significant workforce shortage. Demand for imaging is projected to outpace the supply of radiologists through 2055. To mitigate this, health systems are utilizing teleradiology for remote image interpretation and to provide access to subspecialists. - Reimbursement models are also evolving, with the 2025 Medicare Physician Fee Schedule proposing an overall 2.83% reduction in the conversion factor, which will impact many radiology procedures. However, specific procedures like coronary computed tomography angiography (CCTA) will see a significant payment increase. - The model of interventional radiologists being part of a diagnostic radiology group is expected to evolve, with more IRs contracting directly with hospitals or joining specialized IR groups. This shift allows for greater focus on the distinct clinical and procedural aspects of interventional radiology. - As IR procedures become more complex, there is a growing trend of these services being performed in office-based settings, which can be more profitable due to global fee revenue that is multiples greater than professional fees alone. For example, the hospital outpatient fee for a lower extremity revascularization case can be over $15,000, with an additional professional fee of over $1,100.
